ALXO - ALX Oncology Announces November Investor Conference Participation | Benzinga
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology") (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that management will participate in three upcoming investor conferences in November.
2023 UBS BioPharma Conference
Format: Fireside chat with analyst, Dr. Colin Bristow
Date: Wednesday, November 8th
Time: 1:30 PM EST
Location: Miami Beach, FL
Webcast link: Available here
2023 Jefferies London Healthcare Conference
Format: Fireside chat with analyst, Michael Yee
Date: Tuesday, November 14th
Time: 3:00 PM GMT
Location: London, UK
Webcast link: Available here
2023 Piper Sandler Healthcare Conference
Format: Fireside chat with analyst, Christopher Raymond
Date: Tuesday, November 28th
Time: 4:30 PM EST
Location: New York, NY
Webcast link: Available here
The live webcasts for the UBS, Jefferies and Piper Sandler fireside chats can be accessed by visiting the Investors ...